Contact Us
Drug Search Results
More Filters [+]

Tefinostat

Alternative Names: tefinostat, chr-2845, chr2845, chr 2845
Latest Update: 2020-01-09
Latest Update Note: News Article

Product Description

Mechanisms of Action: HDAC Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Chroma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tefinostat

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatocellular Carcinoma|Leukemia

Phase 1: Acute Myeloid Leukemia|T-Cell Cutaneous Lymphoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Monocle

P2

Completed

Leukemia

2019-05-31

CHR-2845

P2

Unknown status

Hepatocellular Carcinoma

2018-12-01

CHR258 in HCC

P2

Terminated

Hepatocellular Carcinoma

2017-12-14

CHR-2845-001

P1

Completed

T-Cell Cutaneous Lymphoma|Acute Myeloid Leukemia

2011-07-01

Recent News Events

Date

Type

Title

01/09/2020

News Article

 Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions